Pharmaceutical

FDA approves new administration routes for Xcopri 

SK Life Sciences Xcopri (cenobamate) is approved as an oral suspension mixed with water for mouth administration or via a nasogastric tube.

Apr 13, 2024 - 00:00
FDA approves new administration routes for Xcopri 
SK Life Sciences Xcopri (cenobamate) is approved as an oral suspension mixed with water for mouth administration or via a nasogastric tube.
Read the original article

Tags:

Previous Article

UK charities condemn continued drug shortages

Next Article

Candel wins FDA orphan drug designation for pancreatic cancer drug

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: U.S. appeals court strikes down key provisions in Oklahoma law that regulates PBMs

STAT+: U.S. appeals court strikes down key provisions i...

Aug 17, 2023

FDA grants approval for Pfizer’s RSV vaccine

FDA grants approval for Pfizer’s RSV vaccine

Aug 22, 2023

Sanofi/Regeneron’s Dupixent set to dominate COPD biologics market following FDA approval

Sanofi/Regeneron’s Dupixent set to dominate COPD biolog...

Sep 28, 2024